S

START Center for Cancer Research

Phase 1 cancer trials with genomic profiling

Director, Investigational Drug Section

PharmacyPosted on Nov 5
Full-timeAtlanta, GA, USANo salary listed

About the Job

Requirements

  • Graduate of an ACPE-accredited School of Pharmacy.
  • Hold a current state license.
  • Have previous hospital or clinic pharmacy experience.
  • Be familiar with sterile compounding requirements for chemotherapy agents, USP <797> and USP <800>, laminar airflow hoods, and biological safety cabinets.
  • Have computer skills, including use of Microsoft Office products: Word, Excel, PowerPoint, and Access.
  • Be familiar with electronic medical record programs, pharmacy software programs, and study IRT systems.
  • Know Good Clinical Practice principles.
  • Hold sterile compounding and chemotherapy certification.
  • Have intravenous sterile product training.
  • Have prior experience in clinical trials and management of investigational drugs.
  • Be able to spend 80% of work time standing and/or walking.
  • Be able to lift up to 25 pounds and perform intermittent lifting, bending, pushing, and/or pulling.

Responsibilities

  • Oversee all components of Investigational Drug Section operations at the assigned site and fulfill clinical pharmacist duties, including medication order verification, dispensing, and documentation for investigational drugs, conventional chemotherapy, and supportive care medications.
  • Practice with a high degree of autonomy guided by Investigational Drug Section standard operating procedures and quality assurance verification guidelines.
  • Supervise staff assigned to medication preparation, dispensing, and Investigational Drug Section operations in accordance with applicable rules and regulations; directly supervise site-specific pharmacists and pharmacy technicians.
  • Partner with the Director of Nursing and study operations leader to maintain efficient, high-quality patient care.
  • Collaborate with site leadership, shared services leaders, and integration team members to align workflows and processes.
  • Ensure Investigational Drug Section space meets local and federal expectations and comply with applicable internal standard operating procedures.
  • Verify medication orders for dosage and calculation accuracy and review basic patient eligibility criteria, including signed and dated study consent forms, laboratory values within treatment criteria, completion of required tests, resolution of known toxicity from prior chemotherapy, and absence of serious known drug interactions.
  • Oversee Investigational Drug Section medication preparation and dispensing, including supervision of certified pharmacy technicians preparing intravenous admixtures and oral medication dosages, and ensure completion of double-check verification before releasing dosages.
  • Provide pharmaceutical care, including patient medication and supportive care counseling and drug information to the healthcare team and patients.
  • Oversee drug inventories, including documentation, projected usage, ordering, receiving, storage, and dispensing tracking for Phase I and conventional medications.
  • Assist pharmacy technicians with investigational documentation, records, weekly inventory, and interactions with study personnel.
  • Review new protocols, protocol amendments, and associated forms.
  • Maintain and generate reports using the Investigational Drug Section drug accountability program.
  • Contribute to effective pharmacy department operations by entering accurate medication orders in the computer system and accurately maintaining reported patient home medications in the electronic medical record.
  • Travel less than quarterly to support new site activation.

Desired Qualifications

  • Have a specialty residency in oncology and/or current Board Certified Oncology Pharmacist certification.

About the Company

START Center for Cancer Research

Phase 1 cancer trials with genomic profiling

START Center for Cancer Research runs Phase 1 clinical trials for novel anti-cancer therapies through a network of research sites in the United States, Spain, Portugal, and Ireland. It connects patients with early-stage trials, supported by genetic tumor profiling, multi-disciplinary care, and state-of-the-art treatment technology, to test new drugs before they reach broader use. The center distinguishes itself by its large, community-based trial network with 40+ principal investigators and a track record of conducting over 1,500 early-phase trials, including 50 therapies that later gained FDA/EMA approval. Its goal is to speed the translation of clinical research into available treatments and to expand access to innovative options for patients and physicians worldwide.

Company size
11-50
Company stage
Not listed
Total funding
Not listed
Headquarters
San Antonio, TX
Founded
Not listed

Recently Posted Jobs

Explore more opportunities at START Center for Cancer Research

See more jobs